Genentech: Home

Skip to Content for Home About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu

News & Features

		Inspiring Patients Every day Genentech employees are reminded by patient displays around the company's campuses that their dedication is making a difference. Watch the video.



		Accelerated Approval for Avastin in Breast Cancer The FDA has granted accelerated approval for Avastin in combination with paclitaxel chemotherapy for the first-line treatment of advanced HER2-negative breast cancer.

DNA NYSE: Quote: 97.00 | Change: 0.11 | 08.08.08 | 14:55:00

SCIENTIFIC LEADERSHIP >> Genentech's scientists are some of the most prolific in the industry and in their fields.



DEVELOPMENT PIPELINE >> Genentech's pipeline continues to grow, with more than 100 promising projects in development.

Patient Access >>

Genentech is committed to making sure price is not a barrier to access for patients.

Roche Proposal >>

July 24, 2008 press release
July 21, 2008 press release

Awards and
Recognition >>

FORTUNE magazine has named Genentech to its "100 Best Companies to Work For" and "America's Most Admired" lists.